Assessment of epidemiological situation of chronic hepatitis C in Samara Region
https://doi.org/10.33667/2078-5631-2020-18-52-54
Abstract
Research objective. Analysis of the features of the manifestations of the epidemic process of chronic hepatitis C (HCV) in Samara Region from 1997 to 2018. Materials and methods. The data of official statistics were analyzed: the materials of the Federal Service for Supervision in the Field of Consumer Protection and Human Welfare, the Office of the Federal Service for Supervision in the Field of Consumer Protection and Human Welfare in Samara Region. Results. From 1997 to 2016, in the Samara region there is a periodic wave-like increase in the incidence of HCV with small decreases in indicators from 5.2 to 58.00⁄0000 – by 11.16 times (p < 0.01). From 2017 to 2018 there was a slight decrease in the incidence of HCV in Samara Region from 58.0 to 56.20⁄0000. The maximum incidence of HCV of the children's population of Samara Region was noted in 2002 and 2012 and amounted to 7.1 and 7.20⁄0000. The minimum incidence rate of HCV was observed in 2017 at 1,90⁄0000. Studying features of manifestation of epidemic process of chronic hepatitis, risk factors is necessary for the subsequent development of actions for prevention of growth of a disease and to forecasting of development of incidence.
About the Authors
O. V. Churbakovа
Samara State Medical University
Russian Federation
Samara
Russian Federation
Samara
V. G. Akimkin
Central Research Institute of Epidemiology
Russian Federation
Moscow
Russian Federation
Moscow
D. V. Pechkurov
Samara State Medical University
Russian Federation
Samara
Russian Federation
Samara
References
1. Plotnikova E. Yu., Karyagina M. S., Shamray M. A., Zinchuk S. F., Baranova E. N., Maksimov S. A. Magniyevo-tsinkovyy status u patsiyentov s khronicheskimi gepatitami В i С. RMZh Meditsinskoye obozreniye. 2017; 2: 60–64 (In Russian).
2. Makashova V. V., Omarova H. G., Hohlo va O. N., Lukashenko T. N. Hronicheskij virusnyj gepatit S s iskhodom v cirroz i gepatocellyulyarnuyu karcinomu. RMZH Medicinskoe obozrenie. 2018; 8 (II): 92–96 (In Russian).
3. Csete J., Elliott R., Fisher B. Viral Time Bomb: Health and Human Rights Challenges in Adressing Hepatitis C in Canada. Toronto: Canadian HIV/AIDS Legal Network, Centre for Additions Research of BC and Centre for Applied Research in Mental Health and Addiction. (Электронный ресурс). URL: http://www.aidslaw.ca/site/wp-content/uploads/2013/11/ViralTimeBomb-ENG.PDF (дата обращения: 15.04.2017).
4. Konstantinov D. Yu. Vliyanie protivovirusnoj terapii i genoma virusa na stepen’ vyrazhennosti zhirovogo gepatoza u bol’nyh s hronicheskim gepatitom C s lipidnym stress-sindromom. Aspirantskij vestnik Povolzh’ya. 2016; 16 (1–2): 82–86 (In Russian).
5. Shahgil’dyan I.V., Mihajlov M. I., Onish chenko G. G. Parenteral’nye virusnye gepatity (epidemiologiya, diagnostika, profilaktika). M. VUNMC MZRF. 2015; 384 (In Russian).
6. Kornilova E. B., Ermolaeva A. D., Davydovskaya M. V., Ermolaeva T. N., Polyakova K. I., Holovnya-Voloskova M.E., Kokushkin K. A. Organizaciya medicinskoj pomoshchi i lekarst vennoe obespechenie bol’nyh hronicheskim gepatitom S: sovremennoe reshenie aktual’noj problemy. Klinicheskaya farmakologiya i terapiya. 2017; 26 (5): 92–96 (In Russian).
7. Simmons B, et al. Long-term treatment out comes of patients infected with hepatitis C virus: a systematic review and meta-analysis of the survival benefit of achieving a sustained virological response. Clin Infect Dis 2015; 61 (5): 730–40.
8. Yаroshenko E. B., Mojsyuk YA.G. Aktual’naya problema: lechenie HCV infekcii v posttransplantacionnom periode. Transplantologiya 2010; 1: 112–4 (In Russian).
9. Got’e S.V., Mojsyuk YA.G., Poptsov V. N. i dr. Otdalennye rezul’taty transplantacii trupnoj pecheni. Vestnik transplantologii i iskusstvennyh organov 2014; 16 (3): 45–53 (In Russian).
10. Kornilova E, Kornilov M, Moysyuk Y, Gautier S. Evaluation of results HCV treatment after liver transplantation. Transplantation 2016; 100 (5S): S 181.
11. Kornilova E, Tsirulnikova O, Kornilov M, Gautier S. HCV treatment after liver transplantation 2006–2016: result assessment. Transplantation 2016; 100 (7S): S 573.
12. Patlusov E. P., Ponezheva ZH.B., Mannanova I. V. Rol’ metabolicheskih i immunologicheskih narushenij v progressirovanii hronicheskogo gepatita S. RMZH. 2019; 10: 7–11 (In Russian).
13. Chulanov V. P., Isakov V. А., Zhdanov К. V., Bakulin I. G., Burnevich E. Z., Latarska-Smuga D. Intermediate results of the international multicenter prospective observational study MOSAIC on the assessment of epidemiology, subjective and economic outcomes of treatment of chronic hepatitis C. Infectious diseases. 2018; 16 (1): 5–14 (In Russian).
Review
For citations:
Churbakovа O.V., Akimkin V.G., Pechkurov D.V. Assessment of epidemiological situation of chronic hepatitis C in Samara Region. Medical alphabet. 2020;(18):52-54. (In Russ.) https://doi.org/10.33667/2078-5631-2020-18-52-54
Views:
327
Email this article 